No Data
No Data
(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest
Alnylam Pharmaceuticals's (NYSE:ALNY) short percent of float has risen 4.82% since its last report. The company recently reported that it has 2.63 million shares sold short, which is 2.39% of all regu
S&P 500 Futures Rise In Premarket Trading; GameStop, Deere Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Chubb Ltd. (CB) was up 8.0% in pre-market trading,
Most Attractive Short-term Overwriting Stocks for June Expiration - Goldman
Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events.
S&P 500 Futures Steady In Premarket Trading; Monday.Com, Nextracker Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, monday.com Ltd. (MNDY) was up 19.4% in pre-market t
10 Health Care Stocks With Whale Alerts In Today's Session
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.
HC Wainwright Adjusts Price Target on Alnylam Pharmaceuticals to $400 From $395, Maintains Buy Rating
Alnylam Pharmaceuticals (ALNY) has an average outperform rating and a price target range of $138 to $400, according to analysts polled by Capital IQ.